Drugs Gene Silencing Pharma Companies Protein 
Drug Discovery World
OCTOBER 4, 2022
DDW Editor Reece Armstrong explores some of the trends that will be featured in sessions throughout ELRIG Drug Discovery 2022 and the news behind them. In the UK, effort has been made to scale-up the country’s cell and gene therapy manufacturing capabilities. Screening acts as the bedrock of many drug discovery activities.
Delveinsight
AUGUST 6, 2020
Transthyretin (TTR) is a protein that the liver produces to facilitate the transfer of thyroid hormone and vitamin A in the blood. However, due to specific reasons, the TTR protein begins to misfold and aggregate as fibrils, a process known as amyloidosis of Transthyretin (ATTR). Gene-silencing Therapies.
Expert insights. Personalized for you.
52 
Let's personalize your content